BG

Bellevue Group Portfolio holdings

AUM $5.28B
1-Year Est. Return 50.12%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+50.12%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$7.07B
AUM Growth
+$1.91B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
231
New
Increased
Reduced
Closed

Top Buys

1 +$32.1M
2 +$27.9M
3 +$24.7M
4
BMY icon
Bristol-Myers Squibb
BMY
+$24.3M
5
DVA icon
DaVita
DVA
+$23.4M

Top Sells

1 +$78.8M
2 +$34.5M
3 +$34.1M
4
MRNA icon
Moderna
MRNA
+$33.1M
5
AKCA
Akcea Therapeutics Inc
AKCA
+$26.9M

Sector Composition

1 Healthcare 96.05%
2 Industrials 0.58%
3 Technology 0.42%
4 Communication Services 0.29%
5 Financials 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
201
$331K ﹤0.01%
8,500
202
$319K ﹤0.01%
4,334
203
$318K ﹤0.01%
5,000
204
$311K ﹤0.01%
3,000
205
$275K ﹤0.01%
6,200
206
$234K ﹤0.01%
4,107
207
$100K ﹤0.01%
60,000
208
$27K ﹤0.01%
1,520
209
-3,000
210
-8,500
211
-29,900
212
-1,529
213
-6,100
214
-1,504
215
-57,100
216
-750
217
-102,000
218
-94,860
219
-20,400
220
-113,955
221
-87,327
222
-13,600
223
-552,800
224
-303,000
225
-100,000